Kaiser A B
Department of Medicine, Saint Thomas Hospital, Nashville, Tennessee 37202.
Am J Surg. 1988 May 31;155(5A):52-5. doi: 10.1016/s0002-9610(88)80213-7.
After an uncertain and highly controversial beginning, the use of antimicrobials for prophylaxis of surgical wound infection has evolved to represent state-of-the-art management of the surgical patient. Although a truly ideal prophylactic antimicrobial does not exist, the cephalosporins, particularly those of the first generation, have emerged as the mainstay of prophylaxis in surgery. However, new pathogens and newly recognized problems have necessitated a comparative evaluation of a wide variety of antibiotic regimens. The choice of an appropriate antibiotic is complicated by the lack of an adequate experimental model of infection in clean and clean-contaminated surgical procedures. Moreover, clinical trials have proved to be an inefficient method of comparing antibiotic regimens, as important variations in risk factors for infection cannot be reliably controlled. Significant differences exist among cephalosporins and between the cephalosporins and other classes of antimicrobials in several clinically important parameters: antimicrobial spectrum, serum half-life, ease of administration, tissue penetrability, cost, and incidence of allergy and toxicity. New generations of cephalosporins and new classes of antibiotics have demonstrated the potential to out-perform the first-generation cephalosporins in many of these areas. Although the first-generation cephalosporins were essential in establishing the efficacy of antibiotic prophylaxis in surgery, there are no guarantees that this class of cephalosporin, or that any cephalosporin, for that matter, will continue to dominate the prophylactic arena.
在经历了一个不确定且极具争议的开端后,用于预防手术伤口感染的抗菌药物的使用已发展成为外科患者的先进管理方法。尽管真正理想的预防性抗菌药物并不存在,但头孢菌素,尤其是第一代头孢菌素,已成为手术预防的主要药物。然而,新的病原体和新发现的问题使得有必要对各种抗生素方案进行比较评估。在清洁和清洁-污染的外科手术中,由于缺乏足够的感染实验模型,选择合适的抗生素变得复杂。此外,临床试验已被证明是比较抗生素方案的低效方法,因为感染危险因素的重要差异无法得到可靠控制。在几个临床重要参数方面,头孢菌素之间以及头孢菌素与其他类抗菌药物之间存在显著差异:抗菌谱、血清半衰期、给药便利性、组织穿透性、成本以及过敏和毒性发生率。新一代头孢菌素和新型抗生素已显示出在许多这些方面优于第一代头孢菌素的潜力。尽管第一代头孢菌素对于确立手术中抗生素预防的疗效至关重要,但不能保证这类头孢菌素或任何头孢菌素会继续在预防领域占据主导地位。